Try our Advanced Search for more refined results
Health - December, 2010
177 articles
- Health Care Regulation To Watch In 2011
- Considering New Expert Disclosure Requirements
- Fed. Circ. Nixes Deal In Sun Pharma Eloxatin Suit
- Genentech Fights FDA's Downgrade Of Avastin
- SEC Sues InterMune Options Buyers Over Inside Tips
- Consumers Lose 2nd Class Cert. Bid In Quest Fight
- Pfizer Yanks More Lipitor After Odor Problems
- FDA Announces Recall Of Abbott Diabetic Test Strips
- RyMed To Fight Infringement Verdict Over IV Patents
- US Joins Qui Tam Suit Over Mayo Medicare Claims
- Ex-UBS Banker Pleads Guilty To Insider Trading Scheme
- Defeating Joinder In Medical Device And Drug Cases
- Sales Reps Hit Daiichi Sankyo With FLSA Action
- 6th Circ. Asked To Rehear Blue Cross ERISA Action
- Obama Inks $250B Short-Term Funding Bill
- Odyssey Settles Shareholder Suits Over Gentiva Merger
- Regulator Shouldn't Argue For Blue Cross, Fund Says
- Metabolite Says LabCorp Must Pay Up After IP Re-Exam
- HHS Wants Health Insurers To Justify Rate Hikes
- Cleary Gottlieb Reps DSM In $1B Martek Acquisition
- DOJ Says SAIC Decision Supports Blackstone FCA Case
- Senate Sends Short-Term Spending Bill To House
- Wyeth Beats W.Va. Fraud Suit Over Hormone Drugs
- Judge Nixes Mass. Hospital Workers' State Law Claims
- Wyeth Loses Bid To Take Novartis IP Suit To Calif.
- Dey To Pay $280M To End Drug Price Inflation Suit
- US Aims To Protect Scientists From Politics
- Bill Seeks Overhaul Of Global Drug Safety Rules
- Cobalt Defense Nixed In Suit Over Generic Boniva
- Dow Corning Gets Breast Implant Win In 6th Circ.
- NYC Settles Jewish Nurse's Bias Claims
- Oracle Drug Software Infringes Patent, Suit Says
- ACO Payment Methods: The Middle Path Is Best
- Staff Atty, OPM Battle Over Same-Sex Spouse Benefits
- Issa Seeks FDA Probe Into Maker Of Recalled Rolaids
- Bilski Doesn't Doom Prometheus Patents: Fed. Circ.
- Ex-CV Sales Rep Drops Ranexa Marketing Suit
- Pharma Co. Says Insurer Owes It For Reactor Shutdown
- Aflac Faces Class Action Over Ineligible Premiums
- FDA Finds Quality Breaches At J&J Drug Plant
- Mylan Faces Suit Over Orapred ANDA
- GAO Denies Protest Over Iraq Health Care Contract
- Health Providers' New Compensation Deduction Limit
- Blue Cross Michigan Calls DOJ Antitrust Suit Flawed
- Contraceptive Makers Denied Quick End To Patent Suit
- Novo, Sandoz Reach Deal Over Generic Prandin
- Senate Scraps $1.1T Spending Bill
- Bioethics Panel OKs Synthetic Bio, Urges Oversight
- Siemens Partially Off Hook In Lab Test Patent Suit
- Medicis Hits Nycomed Unit With 3rd Vanos Patent Suit
- Fen-Phen Atty Deserved Policy Rescission: Insurer
- La. Judge Scraps Blue Cross HMO State Contract
- FTC Urges 11th Circ. To Revive Pay-For-Delay Case
- US Criticizes Planned Parenthood In Overbilling Case
- Generics Cos. Prevail In AstraZeneca's Crestor Suit
- Case Study: FTC V. Ovation
- HoMedics Didn't Infringe Scale Patent: Fed. Circ.
- Feds Defend 10-Year Sentence For InterMune Exec
- Elan, Eisai To Pay $214M Over Zonegran Marketing
- FDA Moves To Pull Breast Cancer Approval For Avastin
- Pfizer Wins OK For $75M Deal In Shareholder Suits
- Fed. Circ. Kills Tribe's Suit Over Health Care Deficit
- Stryker Sues Zimmer Over Wound System Patent
- FDA Warns Of Hidden Ingredients In Supplements
- Feds Reverse Course, Intervene In Guidant FCA Suit
- NY State Sen., Son Plead Not Guilty To Embezzlement
- Teva's $70M ARS Suit V. Deutsche Tossed For Good
- Covidien Unit Targets Watson Over Generic Exalgo
- Senate Unveils $1.1T Omnibus Spending Bill
- Illumina Suit Over Gene Tech Patents Gets The Boot
- Novartis Finishes Up $51.6B Alcon Purchase
- 3rd Circ. Won't Revive Cephalon Shareholder Case
- Fla. Court Affirms $28.3M RJ Reynolds Verdict
- FDA Warns Airgas Over Poor Records, Contamination
- No Double Jeopardy In Atty Fraud Suit: 5th Circ.
- J&J Hit With $50M Verdict In Pa. Medicare Suit
- Skadden Reps HCP In $6.1B Nursing Home Deal
- 6th Circ. Tosses Supplement Tycoon's 25-Year Stint
- Teva Settles In Bayer Suit Over Generic Yaz
- DOJ Fights Virginia Health Care Ruling In 4th Circ.
- Ex-Professor Can't Toss St. John's Drug Research Suit
- Matrixx To Pay $15.5M In Zicam MDL
- Purdue Execs Can't Shake Ban From Federal Funds
- Judge OKs $27M Deal In Cooper Securities Action
- Vitamin Maker To Pay FDA $2M Over Health Claims
- Mylan Asks High Court To Review Generics Rulings
- 8th Circ. Shuts Down Medtronic ERISA Action
- Calif. Regulator Blocks PacifiCare Dividend
- Galderma Offers $978M For Sweden's Q-Med
- InSight Seeks To Cut Debt By $290M In New Ch. 11
- High Court Won't Consider Medical Device Case
- AntiCancer Sues Cellsight Over Tumor Detection IP
- Congress Can't Require Health Insurance, Judge Says
- Supreme Court Seeks US Input On Definiteness
- Supreme Court To Rule On Generics Labeling Laws
- MMSEA And Product Liability Claims
- Ex-Canopy CEO Admits To Wire Fraud In $93M Scheme
- Blue Cross, Others Booted In Pfizer Neurontin MDL
- Cornell Fails To Nix Verdict In AIDS Research Suit
- Japan Orders J&J To Nix Acuvue Price-Display Ban
- Settlement OK'd In UPS Retirees' Insurance Rate Action
- HHS Clamps Down On Mini-Med Insurance Plans
- Molecular Insight Enters Ch. 11 With $45M Finance Plan
- 2 Accused In Sequenom, EXAS Insider Trading Case
- Kirkland Advises CHS In $3.3B Bid For Tenet
- VNUS Wins $45M Jury Verdict In Medical Laser IP Suit
- Morrison Cohen Reps North Castle In Atkins Sale
- Pfizer Used Corruption Info To Pressure Official: Cable
- Humana Drops Walgreen Drug Plan Comparisons Suit
- Mental Health: Fair Game In Disability Cases?
- Pfizer Pulls Hypertension Drug Thelin From Market
- Fed. Circ. Nixes ERBE's Latest Endoscopy IP Suit
- Feds Subpoena Medtronic Over Neurostimulator Sales
- J&J Unit Recalls 13M Packages Of Rolaids
- Appeals Board Keeps Lockheed Contract Suit Alive
- NJ Doctors To Take Health Reform Suit To 3rd Circ.
- Senate Republicans Block 9/11 Health Bill
- Whistleblower Suit Over Bone Growth Device Stays Put
- 6th Circ. Affirms Toss Of Blue Cross ERISA Action
- Senate Delays Medicare Cuts To Doctor Rates By 1 Year
- 4th Circ. Affirms UK Jurisdiction In Contract Spat
- J&J Hit With $1.8M Verdict In Levaquin MDL
- 6 Cases Move Forward In Novartis MDL Over Bone Drugs
- Sales Rep Hits Merck With Overtime Class Action
- EU Fines French Pharmacists €5M For Price-Fixing
- The Long Arm Of The FTC Reaches Even Approved Deals
- Cravath Reps J&J In $2.3B Bid For Crucell
- 4 More Charged In Alleged $14.5M Medicare Fraud
- Exactech To Pay $3M To Settle Kickbacks Case
- SEC, DOJ Sue MediSys Over Alleged Kickback Schemes
- Ark. Court Backs Class Cert. For Insurance Customers
- Abbott, Others To Pay $421M Over Drug Price Hikes
- Medicare Stent Scam Cost $3.8M, Senate Report Says
- Cipro Buyers Urge High Court To Rule On Pay-For-Delay
- Fla. Workers Win Class Cert. In Wellness Program Suit
- 9th Circ. Nixes En Banc Bid In Humana Marketing Suit
- Philips' Suit Over Defibrillator Patent Stays Alive
- Aetna To Scoop Up Health Tech Co. Medicity For $500M
- Reckitt, Watson Drop Patent In Suit Over Mucinex ANDA
- The End Of Class Actions? Not Likely
- Pfizer Proposes $75M Fund To Settle Shareholder Suits
- Pfizer Wins Verdict In Suit Over Prempro-Cancer Link
- Judge Tosses Cigna Case Managers' FLSA Class Action
- DOI To Rethink Bids On $30M Health IT Contract
- Pharmacy Drops Provigil Class Suit Against Cephalon
- Cigna Wins Toss Of Disability Plan Class Action
- Case Study: Nightingale V. Anodyne
- Humana Sues Walgreen Over Drug Cost Comparisons
- Shire Sues Impax, Watson Over Generic Intuniv
- McNeil Asks High Court To Review Drug Failure To Warn
- GAO Upholds Cigna's $248M Medicare Contract
- Mount Sinai Hospital Official Cops To Bid-Rigging
- 15-Year Sentence Reinstated For National Century Exec
- Judge Tosses Part Of Ex-Wyeth Exec's Firing Suit
- Mayo Sues BP To Collect Oil, Gas Royalties
- What To Do When Seed Money Gets Personal
- EU Antitrust Raids Target AstraZeneca
- Allergan False Marking Case Survives Dismissal Bid
- Healthways To Settle ERISA Class Action For $1.25M
- AstraZeneca Seeks To Halt Mylan's 2nd Seroquel ANDA
- Stryker Loses Bid To Toss Pain Pump Suits
- Momenta, Sandoz Sue Teva Over Lovenox Generic
- RJ Reynolds Agrees To Meet With AGs On Marketing
- J&J Recalls Mylanta To Revise Alcohol Labeling
- Health Provider Loses Cert. Bid In State Farm Suit
- Univ. Of Wash. Targets GE Over Ultrasound Patent
- Ex-GSK Atty Pleads Not Guilty To FDA Probe Charges
- EU, India Near Settlement In Drug Seizure Row
- CareCore Hit With $34M Verdict In Antitrust Suit
- Mo. Hospitals To Pay $2.2M To Settle FCA Claims
- Liberty University Aims To Revive Health Care Suit
- FTC Challenges LabCorp's Westcliff Acquisition
- DOJ, FTC Chided For Insurance Antitrust Efforts
- Novo Patent Fight Over Prandin To Stay In Minn.
- Plaintiffs Exit Bayer MDL But Still Face Discovery
- Ropes & Gray Reps Axcan In $583M Eurand Deal
- The SEC's Lessons For Medical Consultants